UPDATED Jun 15, 2025
Discover large cap Norwegian Pharmaceuticals & Biotech companies that are on the OSEAX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PHO | NOK 51.10 | -0.8% | -20.9% | NOK 1.4b | NOK 82.50 | PE635.9x | E89.1% | 0% | ||
VISTN | NOK 24.30 | 0.4% | 9.0% | NOK 1.1b | n/a | PE14x | n/a | 5.1% | ||
AZT | NOK 16.75 | 4.4% | -31.2% | NOK 855.4m | NOK 17.00 | PE390.3x | E75.5% | n/a | ||
HBC | NOK 2.05 | -3.3% | 1.5% | NOK 842.7m | n/a | PS3.1x | n/a | n/a | ||
TRMED | NOK 2.64 | 3.7% | 154.3% | NOK 830.0m | n/a | PB2.5x | n/a | n/a | ||
LYTIX | NOK 9.48 | 10.2% | 19.7% | NOK 647.1m | NOK 13.00 | PS1064.3x | S39.7% | n/a | ||
NYKD | NOK 1.84 | 7.0% | -87.2% | NOK 600.8m | NOK 6.75 | PS7.3x | E1.1% | 51.5% | ||
NORD | NOK 80.00 | 0% | n/a | NOK 410.5m | n/a | PE3.3x | n/a | 0% | ||
NAVA | NOK 21.50 | -3.2% | -37.3% | NOK 379.7m | NOK 34.00 | PB1.8x | E90.4% | n/a | ||
ZLNA | NOK 14.15 | 1.1% | n/a | NOK 289.4m | n/a | PS5460.9x | E-26.3% | n/a | ||
EXTX | NOK 2.96 | 9.6% | -60.0% | NOK 187.3m | n/a | PB1.6x | n/a | n/a | ||
ONCIN | NOK 1.85 | 0% | n/a | NOK 180.8m | NOK 2.70 | PS22.3x | E6.5% | n/a | ||
SOFTX | NOK 0.081 | -0.5% | -54.2% | NOK 180.6m | n/a | PS22.8x | n/a | n/a | ||
ABS | NOK 3.77 | 21.6% | -61.1% | NOK 101.3m | n/a | PS2.3x | n/a | n/a | ||
PCIB | NOK 1.68 | 5.7% | -16.3% | NOK 62.5m | n/a | PS9.3x | n/a | n/a | ||
CRNA | NOK 0.62 | -7.6% | -76.0% | NOK 61.6m | NOK 1.00 | PE1.1x | n/a | n/a | ||
BGBIO | NOK 1.37 | -1.0% | -88.2% | NOK 53.5m | NOK 1.90 | PS63.1x | E12.9% | n/a |